GOTHENBURG, SE / ACCESS Newswire / February 20, 2026 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson’s disease, today announced that its scientific advisory board has provided important …
Thursday, September 10, 2026
